Damaged intestinal barrier can facilitate the development of local diseases such as irritable bowel disease, inflammatory bowel disease or celiac disease, but also the development of systemic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, hepatitis, and lupus erythematosus, neurodegenerative or psychiatric conditions, or metabolic diseases such as diabetes or obesity
- USB
BPC-157 increases the expression of growth hormone receptors on fibroblasts, boosting the longevity of these cells and thus their ability to promote soft tissue regeneration [3]
Sermorelin is a synthetic growth hormonereleasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1]
Even the parent protein Thymosin Beta-4 completed a Phase 2 trial in 2009, but the results were never published in 15+ years a major red flag suggesting failure
This is where peptides enter the picture